Vimarsana
Biggest News Aggregation in the World

Page 28 - Boxed Warning News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Boxed Warning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Boxed Warning Today - Breaking & Trending Today

ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results - Vimarsana News

ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results

02.11.2023 - ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today reviewed recent progress in the business and reported financial results for the quarter ended September 30, 2023. ...

UCB : presents latest data from generalized myasthenia gravis portfolio at 2023 AANEM Annual Meeting and MGFA Scientific Session -November 01, 2023 at 02:03 am EDT - Vimarsana News

UCB : presents latest data from generalized myasthenia gravis portfolio at 2023 AANEM Annual Meeting and MGFA Scientific Session -November 01, 2023 at 02:03 am EDT

UCB presents latest data from generalized myasthenia gravis portfolio at 2023 AANEM Annual Meeting and MGFA Scientific Session 14 presentations - including 3...

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific Meeting - Vimarsana News

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific Meeting

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, today announced that three scientific abstracts evaluating...

ImmunoGen Announces European Medicines Agency Acceptance of Marketing Authorization Application for Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer - Vimarsana News

ImmunoGen Announces European Medicines Agency Acceptance of Marketing Authorization Application for Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer

ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that the European Medicines Agency has accepted the Marketing...

DAXXIFY® Becomes First Facial Injectable to be Named to TIME's Best Inventions -October 26, 2023 at 08:10 am EDT - Vimarsana News

DAXXIFY® Becomes First Facial Injectable to be Named to TIME's Best Inventions -October 26, 2023 at 08:10 am EDT

- DAXXIFY® for Injection named to TIME’s list of the best inventions of 2023. - DAXXIFY® is a long-lasting peptide enhanced neuromodulator that delivers the first true innovation in...